Aemetis, Inc., a biotechnology company operating within the energy sector, specifically in the oil, gas, and consumable fuels industry, has recently been the subject of market analysis due to its trading performance on the Nasdaq. The company, known for its innovative approach to converting whole plant materials into sugars through engineered bacteria, has these sugars utilized in the biochemical and biofuels industries for the production of various commercial products.
As of March 5, 2026, Aemetis Inc. (AEMT) closed at a price of $1.40 per share. This figure is notably close to the 52-week low of $1.22, recorded on May 7, 2025. The stock has experienced significant volatility over the past year, with a high of $3.66 on July 8, 2025, and a low of $1.22, resulting in a volatility range of $2.44. This indicates substantial price swings within the year, with the stock’s price trajectory showing a pronounced decline of 61.5% from its peak.
The company’s market capitalization stands at $92,240,000 USD, reflecting its current valuation in the market. However, the price-to-earnings ratio is reported at -0.893, suggesting that the company is not currently generating profits, which may be a contributing factor to the stock’s performance.
In terms of recent developments, the last public update from Aemetis Inc. was on February 3, 2026. This update highlighted that its Indian subsidiary had commenced biodiesel deliveries under a $24 million allocation from Oil Marketing Companies (OMCs). Despite this operational milestone, there have been no new catalysts reported that could significantly influence the stock’s price movement in the immediate future.
The trading data provides a snapshot of Aemetis Inc.’s recent performance, indicating a challenging period for the company in terms of stock valuation. The proximity of the current closing price to the 52-week low suggests that the shares are trading closer to their lowest point observed in the past year, underscoring the need for potential investors to closely monitor the company’s future developments and market conditions for any signs of recovery or further decline.
